chr6-133513032-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004100.5(EYA4):c.1495G>A(p.Val499Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000973 in 1,613,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V499G) has been classified as Uncertain significance.
Frequency
Consequence
NM_004100.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.000171  AC: 26AN: 152140Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.000243  AC: 61AN: 251176 AF XY:  0.000214   show subpopulations 
GnomAD4 exome  AF:  0.0000896  AC: 131AN: 1461586Hom.:  0  Cov.: 32 AF XY:  0.0000866  AC XY: 63AN XY: 727110 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.000171  AC: 26AN: 152258Hom.:  0  Cov.: 32 AF XY:  0.000215  AC XY: 16AN XY: 74434 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1J    Uncertain:1 
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 499 of the EYA4 protein (p.Val499Ile). This variant is present in population databases (rs142122118, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 26084686). ClinVar contains an entry for this variant (Variation ID: 534385). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt EYA4 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided    Benign:1 
This variant is associated with the following publications: (PMID: 26084686) -
Cardiovascular phenotype    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at